Independent risk factors and long-term outcomes for acute kidney injury in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study

被引:11
|
作者
Hirano, Daishi [1 ]
Kakegawa, Daisuke [1 ]
Miwa, Saori [1 ]
Umeda, Chisato [1 ,2 ]
Takemasa, Yoichi [1 ]
Tokunaga, Ai [1 ]
Kawakami, Yuhei [1 ]
Ito, Akira [1 ]
机构
[1] Jikei Univ, Dept Pediat, Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1050003, Japan
[2] Saitama Childrens Med Ctr, Div Nephrol, Saitama, Japan
关键词
Acute kidney injury; Matched unrelated donor; pRIFLE; Child; Risk factor; BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; TOTAL-BODY IRRADIATION; ACUTE-RENAL-FAILURE; VENOOCCLUSIVE DISEASE; STATISTICAL-METHODS; CHILDREN; SURVIVORS; NEPHROPATHY; MANAGEMENT;
D O I
10.1186/s12882-020-02045-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Acute kidney injury (AKI) remains a frequent complication in children undergoing hematopoietic stem cell transplantation (HSCT) and an independent risk factor of the patient's survival and a prognostic factor of progression to chronic kidney disease (CKD). However, the causes of these complications are diverse, usually overlapping, and less well understood. Methods This retrospective analysis was performed in 43 patients (28 boys, 15 girls; median age, 5.5 years) undergoing HSCT between April 2006 and March 2019. The main outcome was the development of AKI defined according to the Pediatric Risk, Injury, Failure, Loss, End-stage Renal Disease (pRIFLE) criteria as >= 25% decrease in estimated creatinine clearance. The secondary outcome was the development of CKD after a 2-year follow-up. Results AKI developed in 21 patients (49%) within 100 days after HSCT. After adjusting for possible confounders, posttransplant AKI was associated with matched unrelated donor (MUD) (HR, 6.26;P = 0.042), but not total body irradiation (TBI). Of 37 patients who were able to follow-up for 2 years, 7 patients died, but none had reached CKD during the 2 years after transplantation. Conclusions Posttransplant AKI was strongly associated with HSCT from MUD. Although the incidence of AKI was high in our cohort, that of posttransplant CKD was lower than reported previously in adults. TBI dose reduced, GVHD minimized, and infection prevented are required to avoid late renal dysfunction after HSCT in children since their combinations may contribute to the occurrence of AKI.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Epidemiology, Risk Factors, and Clinical Outcomes of AKI in Pediatric Hematopoietic Stem Cell Transplant Patients
    Ashruf, Omer S.
    Ashruf, Zaid
    Orozco, Zara
    Zinter, Matt
    Abu-Arja, Rolla
    Yerigeri, Keval
    Haq, Imad U.
    Kaelber, David C.
    Bissler, John
    Raina, Rupesh
    KIDNEY360, 2024, 5 (06): : 802 - 811
  • [42] Effectiveness of Long-Term Routine Pulmonary Function Surveillance Following Pediatric Hematopoietic Stem Cell Transplantation
    Prais, Dario
    Sinik, Moran Marx
    Stein, Jerry
    Mei-Zahav, Meir
    Mussaffi, Huda
    Steuer, Guy
    Hananya, Shai
    Krauss, Aviva
    Yaniv, Isaac
    Blau, Hannah
    PEDIATRIC PULMONOLOGY, 2014, 49 (11) : 1124 - 1132
  • [43] Long-term health outcomes of allogeneic hematopoietic stem cell transplantation
    Kelkar, Amar H.
    Antin, Joseph H.
    Shapiro, Roman M.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Acute Kidney Injury and Long-Term Risk for Cardiovascular Events in Patients after Kidney Transplantation
    Rahamimov, Ruth
    van Dijk, Tuvia Y.
    Molcho, Maya
    Vahav, Itay
    Mor, Eytan
    Ben Dor, Naomy
    Goldman, Shira
    Rozen-Zvi, Benaya
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 1149 - 1157
  • [45] Risk Factors for Acute Kidney Injury after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
    Cui, Kai
    Zhang, Senlin
    Li, Jie
    BLOOD PURIFICATION, 2023, 52 (11-12) : 917 - 928
  • [46] Hematopoietic stem cell transplantation for Langerhans cell histiocytosis: clinical findings and long-term outcomes
    Morimoto, Akira
    Kudo, Kazuko
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (09): : 317 - 328
  • [47] Hemorrhagic cystitis in pediatric severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: incidence, risk factors and outcomes
    Cui, Kai
    Zhang, Senlin
    Liang, Mingchu
    He, Chenchen
    Chen, Jie
    Wei, Yufeng
    Hu, Shaoyan
    Li, Jie
    BMC PEDIATRICS, 2025, 25 (01)
  • [48] Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study
    Saglio, Francesco
    Pagliara, Daria
    Zecca, Marco
    Balduzzi, Adriana
    Cattoni, Alessandro
    Prete, Arcangelo
    Tambaro, Francesco Paolo
    Faraci, Maura
    Calore, Elisabetta
    Locatelli, Franco
    Fagioli, Franca
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 433.e1 - 433.e10
  • [49] Incidence and Risk Factors for Acute Kidney Injury after Allogeneic Stem Cell Transplantation: A Prospective Study
    Andronesi, Andreea
    Sorohan, Bogdan
    Burcea, Andreea
    Lipan, Lavinia
    Stanescu, Cristina
    Craciun, Oana
    Stefan, Laura
    Ranete, Adela
    Varady, Zsofia
    Ungureanu, Oana
    Lupusoru, Gabriela
    Agrigoroaei, Gabriela
    Andronesi, Danut
    Iliuta, Luminita
    Obrisca, Bogdan
    Tanase, Alina
    BIOMEDICINES, 2022, 10 (02)
  • [50] A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies
    Saber, Wael
    Steinert, Patricia
    Zhang, Mei-Jie
    Chen, Min
    Pope, Andrea
    Keating, Armand
    Wingard, John R.
    Ballen, Karen
    Stiff, Patrick
    Perales, Miguel-Angel
    Forman, Stephen
    Champlin, Richard
    Langston, Amelia
    Rudebeck, Mattias
    Horowitz, Mary
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 837.e1 - 837.e10